Sleep Disorders Pharmaceutical and Healthcare Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Sleep Disorders Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the pipeline landscape for sleep disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Restless Legs Syndrome, Nocturia and Insomnia, and features dormant and discontinued projects.

Restless Legs Syndrome is a neurologic disorder with a core feature of a distressing, irresistible need or urge to move the legs. Risk factors for RLS include low iron levels, kidney failure, Parkinson's disease, diabetes mellitus, rheumatoid arthritis, and pregnancy.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385279-sleep-disorders-drug-development-pipeline-review-2017

Nocturia, or nocturnal polyuria, describes the excessive urination during night time. Nocturia becomes more common with age and may be symptomatic of the use of diuretic substances, prescription drugs, edema from heart failure, insomnia, pain and prostate or bladder disorders.

Finally, insomnia is a sleep disorder that is characterized by difficulty in falling or staying asleep. Symptoms include difficulty falling asleep at night, waking up during the night, irritability, depression and anxiety.

The size of these pipelines ranges from eight products in restless legs syndrome and nocturia to 31 in insomnia. Across all three of these indications there is a diverse range of molecular targets due to the different pathologies of the indications. The most common targets for restless legs syndrome, nocturia and insomnia therapeutics are D2 dopamine receptor, vasopressin V2 receptor and orexin receptor, respectively.

Scope
- Which companies are the most active within the pipeline for sleep disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of sleep disorders?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Sleep Disorders Report Coverage 7
2.2 Restless Legs Syndrome - Overview 7
2.3 Nocturia - Overview 7
2.4 Insomnia - Overview 7
3 Therapeutics Development 8
3.1 Restless Legs Syndrome 8
3.2 Nocturia 11
3.3 Insomnia 14
4 Therapeutics Assessment 21
4.1 Restless Legs Syndrome 21
4.2 Nocturia 27
4.3 Insomnia 33
5 Companies Involved in Therapeutics Development 39
5.1 Restless Legs Syndrome 39
5.2 Nocturia 42
5.3 Insomnia 44
6 Dormant Projects 53
6.1 Restless Legs Syndrome 53
6.2 Nocturia 53
6.3 Insomnia 54
7 Discontinued Products 56
7.1 Restless Legs Syndrome 56
7.2 Insomnia 56
8 Product Development Milestones 58
8.1 Restless Legs Syndrome 58
8.2 Nocturia 63
…Continued

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/sleep-disorders-pharmaceutical-and-healthcare-pipeline-review-2017/250082

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250082

More News From dailytransparent.com

The Latest: Ex-Chile president's vote rival concedes defeat

Dec 17, 2017

SANTIAGO, Chile — The latest on Chile's presidential runoff election (all times local): 7:55 p.m. The left-of-center candidate in Chile's presidential runoff election has conceded victory to billionaire former President Sebastian Pinera. Sen. Alejandro Guillier told his supporters Sunday night that he had lost and said he called the conservative Pinera to offer congratulations. Officials say the former president has just under 55 percent of the votes to 45 percent for Guillier, with 96 percent of the votes counted. Analysts had expected a closer race, but there had not been any opinion polls on the campaign for several weeks. The...

McCain returning home to Arizona, will likely miss tax vote

Dec 17, 2017

WASHINGTON — Republican Sen. John McCain is returning home to Arizona after being hospitalized for the side effects of his brain cancer treatment and likely will miss a crucial vote on the GOP tax package, President Donald Trump said Sunday. Trump told reporters he had spoken to McCain's wife, Cindy, after her husband had spent about a week at Walter Reed National Military Medical Center in Maryland. "They've headed back, but I understand he'll come if we ever needed his help, which hopefully we won't," Trump said. "But the word is that John will come back if we need his...

South Africa's ruling ANC party votes for new leader Monday

Dec 17, 2017

JOHANNESBURG — South Africa's ruling African National Congress will vote for its new president on Monday, as delegates choose between two candidates to lead Nelson Mandela's historic liberation movement. After a rocky start to the gathering, two candidates accepted the party's nomination for president: Nkosazana Dlamini-Zuma, former African Union commission chair and Zuma's ex-wife, and Deputy President Cyril Ramaphosa, a wealthy businessman who has been increasingly critical of the president. Voting among the more than 4,700 delegates got off to such a late start Sunday that it was postponed until Monday morning, an ANC official told the press. The ANC's...

Ex-President Pinera appears headed back into power in Chile

Dec 17, 2017

SANTIAGO, Chile — Billionaire and former President Sebastian Pinera appeared headed to a victory in Chile's presidential runoff election, with more than 82 percent of the votes counted Sunday night. Officials said Pinera had just over 54 percent of the votes to nearly 45 percent for center-left Sen. Alejandro Guillier. Analysts had predicted a closer race, but there had not been any opinion polls on the election for several weeks. The early results prompted Pinera supporters to celebrate at his campaign headquarters. Pinera won last month's first round, but his 36.6 percent vote share fell far short of what polls...

Trump: I'm not considering firing special counsel Mueller

Dec 17, 2017

WASHINGTON — President Donald Trump said Sunday that he is not considering firing special counsel Robert Mueller even as his administration was again forced to grapple with the growing Russia probe that has shadowed the White House for much of his initial year in office. Trump returned to the White House from Camp David and was asked if he would consider triggering the process to dismiss Mueller, who is investigating whether the president's Republican campaign coordinated with Russian officials during last year's election. The president answered: "No, I'm not." But he did add to the growing conservative criticism of Mueller's...